Stock listing
NASDAQ:LUMO Lumos Pharma Inc Stock
Follow Lumos Pharma Inc into a list and get an email when it puts out news.
Last close · NASDAQ:LUMO
$4.34 USD
Close on Dec 11, 2024 · No longer trades
- Lowest – highest close
- $1.45 – $35.91 USDSince Mar 19, 2020 · lowest Jul 18, 2024 · highest Dec 30, 2020
Delisted NASDAQ:LUMO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:LUMO
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Lumos Pharma Inc on 6ix
- Calls
- 16 calls with a replay · 16 with a transcript · latest Aug 1, 2024
- Decks
- 42 decks · latest Aug 1, 2024
Events
| Call | When | Status |
|---|---|---|
| Lumos Pharma (LUMO) Q2 2024 Earnings Call | Thu, Aug 01, 2024 · 4:30 PM ET | Replay |
| Lumos Pharma (LUMO) Q1 2024 Earnings Call | Wed, May 15, 2024 · 8:30 AM ET | Replay |
| Lumos Pharma (LUMO) Q4 2023 Earnings Call | Thu, Mar 07, 2024 · 4:30 PM ET | Replay |
| Lumos Pharma (LUMO) Q3 2023 Earnings Call | Wed, Nov 08, 2023 · 8:30 AM ET | Replay |
| Lumos Pharma (LUMO) Q2 2023 Earnings Call | Wed, Aug 09, 2023 · 4:30 PM ET | Replay |
| Lumos Pharma (LUMO) Q1 2023 Earnings Call | Wed, May 03, 2023 · 4:30 PM ET | Replay |
| Lumos Pharma (LUMO) Q4 2022 Earnings Call | Wed, Mar 01, 2023 · 4:30 PM ET | Replay |
| Lumos Pharma (LUMO) Q3 2022 Earnings Call | Mon, Nov 14, 2022 · 8:30 AM ET | Replay |
| Lumos Pharma (LUMO) Q2 2022 Earnings Call | Tue, Aug 09, 2022 · 4:30 PM ET | Replay |
| Lumos Pharma (LUMO) Q1 2022 Earnings Call | Tue, May 10, 2022 · 4:30 PM ET | Replay |
All 16 calls
| Call | When | Status |
|---|---|---|
| Lumos Pharma (LUMO) Q4 2021 Earnings Call | Thu, Mar 10, 2022 · 4:30 PM ET | Replay |
| Lumos Pharma (LUMO) Q3 2021 Earnings Call | Wed, Nov 03, 2021 · 4:30 PM ET | Replay |
| Lumos Pharma (LUMO) Q2 2021 Earnings Call | Thu, Aug 05, 2021 · 11:00 AM ET | Replay |
| Lumos Pharma (LUMO) Q1 2021 Earnings Call | Wed, May 05, 2021 · 4:30 PM ET | Replay |
| Lumos Pharma (LUMO) Q4 2020 Earnings Call | Tue, Mar 09, 2021 · 4:30 PM ET | Replay |
| Lumos Pharma (LUMO) Q3 2020 Earnings Call | Tue, Nov 10, 2020 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2024 Earnings Presentation | Earnings | 8 slides | Aug 1, 2024 |
| Investor Presentation (June 2024) | Investor deck | 44 slides | Jun 5, 2024 |
| Q1 2024 Earnings Presentation | Earnings | 14 slides | May 15, 2024 |
| FY2023 Earnings Presentation | Earnings | 10 slides | Mar 7, 2024 |
| Investor Presentation (November 2023) | Investor deck | 57 slides | Nov 15, 2023 |
| Technical Presentation (November 2023) | Technical | 37 slides | Nov 7, 2023 |
| Q2 2023 Earnings Presentation | Earnings | 10 slides | Aug 9, 2023 |
| Technical Presentation (June 2023) | Technical | 42 slides | Jun 21, 2023 |
| Q1 2023 Earnings Presentation | Earnings | 8 slides | May 3, 2023 |
| FY2022 Earnings Presentation | Earnings | 8 slides | Mar 1, 2023 |
All 42 decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Lota S Zoth Other companies: First Financial Bankshares, Inc. (Director · Since at least Apr 28, 2026); enGene Therapeutics Inc. (Director · Since at least Dec 18, 2023); 89bio Inc (Director · Since at least Jun 1, 2020); Inovio Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2019); Zymeworks Inc. (Director · Jan 1, 2019 – Dec 21, 2022 · Past); Spark Therapeutics Inc (CHIEF SCIENTIFIC OFFICER, Director · Jan 6, 2016 – Dec 17, 2019 · Past); Hyperion Therapeutics Inc (Director · Jul 25, 2012 – May 7, 2015 · Past); Orexigen Therapeutics Inc (Director · Apr 26, 2012 – Jul 14, 2017 · Past); Medimmune Inc (SVP, Chief Financial Officer · Feb 23, 2006 – Jun 18, 2007 · Past) | Director · Nov 2, 2012 – Dec 12, 2024 · Past |
| John B Henneman III Other companies: Orthofix Medical Inc. (Director · Since at least Jan 5, 2023); Anika Therapeutics Inc. (Director · Since at least Sep 3, 2020); Aprea Therapeutics, Inc. (Director · Since at least Oct 2, 2019); R1 RCM Inc (Director · Apr 3, 2017 – Nov 19, 2024 · Past); Accretive Health Inc (Director · Feb 16, 2016 – Jan 3, 2017 · Past); SeaSpine Holdings Corp (Director · Jul 1, 2015 – Jan 5, 2023 · Past); Integra LifeSciences Holdings Corporation (CorpVP, CAO · Jan 6, 2006 – Aug 25, 2014 · Past) | Chief Administrative Officer · Oct 1, 2014 – Oct 1, 2018 · Past |
| Paul Edick Other companies: Vistagen Therapeutics, Inc. (Director · Since at least Oct 27, 2025); Xeris Biopharma Holdings, Inc. (See Remarks, Director · Oct 5, 2021 – Jan 31, 2024 · Past); Milestone Pharmaceuticals Inc. (Director · May 8, 2019 – Jun 5, 2020 · Past); Sucampo Pharmaceuticals Inc (Director · Aug 1, 2016 – Feb 13, 2018 · Past); PDL BioPharma Inc (Director · Sep 3, 2015 – Jun 8, 2018 · Past); Neos Therapeutics Inc (Director · Jul 22, 2015 – Jul 3, 2017 · Past); Durata Therapeutics Inc (Chief Executive Officer, Director · Mar 15, 2012 – Nov 17, 2014 · Past) | Director · Nov 10, 2011 – May 12, 2017 · Past |
| Paolo Pucci Other companies: Replimune Group, Inc. (Director · Since at least Apr 1, 2020); West Pharmaceutical Services, Inc. (Director · Since at least Sep 12, 2016); Trillium Therapeutics Inc (Director · Jan 1, 2021 – Nov 17, 2021 · Past); Dyax Corp (Director · Nov 1, 2011 – Jan 13, 2016 · Past); ArQule Inc (Chief Executive Officer, Director · Jun 9, 2008 – Jan 16, 2020 · Past) | Director · Nov 12, 2015 – May 23, 2018 · Past |
| Emmett Cunningham Other companies: NovaBridge Biosciences (Director · Since at least Mar 18, 2026); Annexon, Inc. (Director · Jul 23, 2020 – Jul 23, 2020 · Past); Galera Therapeutics, Inc. (Director · Nov 6, 2019 – Jun 14, 2023 · Past); Venus Concept Inc (Director · Oct 11, 2017 – Oct 11, 2017 · Past) | Director · Mar 18, 2020 – Apr 3, 2020 · Past |
| Joe McCracken Other companies: Savara, Inc. (Nominating & Governance Committee (Chair), Compensation Committee · Since at least Apr 27, 2017); Kindred Biosciences Inc (Director · Apr 20, 2018 – Aug 27, 2021 · Past); Nexvet Biopharma plc (Director · Feb 4, 2015 – Jul 31, 2017 · Past) | Director · Mar 23, 2020 – Dec 12, 2024 · Past |
| Richard J. Hawkins Other companies: Plus Therapeutics, Inc. (Director · Since at least Jun 25, 2020); Savara, Inc. (Audit Committee · Since at least Dec 17, 2017); SciClone Pharmaceuticals Inc (Director · Oct 13, 2017 – Oct 13, 2017 · Past) | Chief Executive Officer, Director · Mar 18, 2020 – Dec 12, 2024 · Past |
| An van Es-Johansson Other companies: Plus Therapeutics, Inc. (Director · Since at least Jan 1, 2020); Savara, Inc. (Audit Committee, Compensation Committee · Since at least Dec 3, 2019) | Director · Feb 16, 2021 – Dec 12, 2024 · Past |
| Eugene Kennedy Other companies: Aprea Therapeutics, Inc. (Chief Medical Advisor · Since at least Oct 16, 2026); Galera Therapeutics, Inc. (Chief Medical Officer · Sep 1, 2022 – Feb 25, 2023 · Past) | Chief Medical Officer · Nov 13, 2017 – Feb 1, 2021 · Past |
| Joseph Saluri Other companies: Cibus, Inc. (General Counsel, EVP-Corp Dev · Jul 20, 2017 – Jul 20, 2017 · Past); Zevra Therapeutics, Inc. (Director · Apr 15, 2015 – Apr 25, 2023 · Past) | Director · Nov 10, 2011 – May 12, 2017 · Past |
All 26 people
| Person | Seat |
|---|---|
| Aaron Schuchart Other companies: Spyre Therapeutics, Inc. (Chief Business Officer · May 22, 2017 – Feb 28, 2019 · Past) | Chief Business Officer · May 19, 2021 – Dec 12, 2024 · Past |
| Brian Wiley Other companies: Aprea Therapeutics, Inc. (Senior Vice President of Corporate Development & Strategy · Since at least Nov 4, 2026) | Chief Commercial Officer · Jan 2, 2013 – Mar 9, 2018 · Past |
| Kevin M Lalande Other companies: Molecular Templates Inc (Director · Jun 3, 2022 – Sep 27, 2024 · Past) | Director · May 5, 2022 – Dec 12, 2024 · Past |
| Thomas A Raffin Other companies: Akoya Biosciences Inc (Director · Since at least Apr 20, 2021) | Director · Nov 10, 2011 – Dec 12, 2024 · Past |
| Bradley J Powers | General Counsel · Aug 3, 2019 – Dec 12, 2024 · Past |
| Carl W Langren | Chief Financial Officer · Nov 7, 2013 – Apr 1, 2021 · Past |
| Chad Allen Johnson | Director · Mar 19, 2018 – Dec 12, 2024 · Past |
| David J Lundquist | Director · Nov 10, 2011 – Mar 5, 2012 · Past |
| Ernest Talarico III | Director · Nov 10, 2011 – Jul 31, 2019 · Past |
| John C McKew | Chief Scientific Officer · Mar 18, 2020 – Dec 12, 2024 · Past |
| Kenneth Lynn | Exec VP of Bus Development · Nov 10, 2011 – Jan 19, 2012 · Past |
| Lori D Lawley | Chief Financial Officer · Aug 1, 2018 – Dec 12, 2024 · Past |
| Nicholas N Vahanian | President · Nov 10, 2011 – Jul 31, 2019 · Past |
| Pisit Duke Pitukcheewanont | Chief Medical Officer · Jan 4, 2024 – Dec 12, 2024 · Past |
| Sarah Alexander | Director · Nov 10, 2011 – Nov 16, 2011 · Past |
| William J Ramsey | Quality Assurance Officer · Nov 10, 2011 – Jun 1, 2015 · Past |
Log in to ask 6ix AI your own questions about Lumos Pharma Inc.